BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2547657)

  • 1. Mu type opioid receptors in rat periaqueductal gray-enriched P2 membrane are coupled to G-protein-mediated inhibition of adenylyl cyclase.
    Fedynyshyn JP; Lee NM
    FEBS Lett; 1989 Aug; 253(1-2):23-7. PubMed ID: 2547657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu-type opioid receptors in rat periaqueductal gray-enriched P2 membrane are coupled to guanine nucleotide binding proteins.
    Fedynyshyn JP; Lee NM
    Brain Res; 1989 Jan; 476(1):102-9. PubMed ID: 2536574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line is coupled to adenylyl cyclase through a pertussis toxin-sensitive guanine nucleotide-binding regulatory protein.
    Lawrence DM; Bidlack JM
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1678-83. PubMed ID: 8103800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of high affinity opioid binding sites in rat periaqueductal gray P2 membrane.
    Fedynyshyn JP; Kwiat G; Lee NM
    Eur J Pharmacol; 1989 Jan; 159(1):83-8. PubMed ID: 2540013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Go mediates the coupling of the mu opioid receptor to adenylyl cyclase in cloned neural cells and brain.
    Carter BD; Medzihradsky F
    Proc Natl Acad Sci U S A; 1993 May; 90(9):4062-6. PubMed ID: 8097884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mu-opioid-receptor-mediated inhibition of the N-type calcium-channel current.
    Seward E; Hammond C; Henderson G
    Proc Biol Sci; 1991 May; 244(1310):129-35. PubMed ID: 1679547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of type II adenylyl cyclase by the cloned mu-opioid receptor: coupling to multiple G proteins.
    Chan JS; Chiu TT; Wong YH
    J Neurochem; 1995 Dec; 65(6):2682-9. PubMed ID: 7595566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ontogeny of mu-, delta- and kappa-opioid receptors mediating inhibition of neurotransmitter release and adenylate cyclase activity in rat brain.
    De Vries TJ; Hogenboom F; Mulder AH; Schoffelmeer AN
    Brain Res Dev Brain Res; 1990 Jun; 54(1):63-9. PubMed ID: 2163782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pertussis toxin on opioid regulation of catecholamine release from rat and guinea pig brain slices.
    Werling LL; McMahon PN; Cox BM
    Naunyn Schmiedebergs Arch Pharmacol; 1989 May; 339(5):509-13. PubMed ID: 2549429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ca2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells.
    Piros ET; Prather PL; Loh HH; Law PY; Evans CJ; Hales TG
    Mol Pharmacol; 1995 May; 47(5):1041-9. PubMed ID: 7746271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. kappa-Opioid receptor-transfected cell lines: modulation of adenylyl cyclase activity following acute and chronic opioid treatments.
    Avidor-Reiss T; Zippel R; Levy R; Saya D; Ezra V; Barg J; Matus-Leibovitch N; Vogel Z
    FEBS Lett; 1995 Mar; 361(1):70-4. PubMed ID: 7890042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
    Puttfarcken PS; Werling LL; Cox BM
    Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid receptor agonists activate pertussis toxin-sensitive G proteins and inhibit adenylyl cyclase in canine cardiac sarcolemma.
    Niroomand F; Mura RA; Piacentini L; Kübler W
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):643-9. PubMed ID: 8938664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opiate-inhibited adenylate cyclase in rat brain membranes depleted of Gs-stimulated adenylate cyclase.
    Childers SR
    J Neurochem; 1988 Feb; 50(2):543-53. PubMed ID: 2826699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
    Noble F; Cox BM
    Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gbetagamma.
    Avidor-Reiss T; Nevo I; Levy R; Pfeuffer T; Vogel Z
    J Biol Chem; 1996 Aug; 271(35):21309-15. PubMed ID: 8702909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid receptor subtypes associated with ventral tegmental facilitation and periaqueductal gray inhibition of feeding.
    Jenck F; Quirion R; Wise RA
    Brain Res; 1987 Oct; 423(1-2):39-44. PubMed ID: 2823993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid-inhibited adenylyl cyclase in rat brain membranes: lack of correlation with high-affinity opioid receptor binding sites.
    Nijssen PC; Sexton T; Childers SR
    J Neurochem; 1992 Dec; 59(6):2251-62. PubMed ID: 1331327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delta-opioid-receptor-mediated inhibition of adenylate cyclase is transduced specifically by the guanine-nucleotide-binding protein Gi2.
    McKenzie FR; Milligan G
    Biochem J; 1990 Apr; 267(2):391-8. PubMed ID: 2159280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.